Evidence map›Paper›PMID 31371405›Full record

ArticleGenetics2019

Tatsuhiro Shimizu, Yuka Kato, Yoshiki Sakai, Naoki Hisamoto, Kunihiro Matsumoto

Abstract read
In one paragraph

Article in Genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Analysis of Caenorhabditis Protein Glycosylation.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  4. Review
  5. The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tatsuhiro Shimizu *Division of Biological Science, Graduate School of Science, Nagoya University, Chikusa-ku, 464-8602, Japan.
Yuka Kato *Division of Biological Science, Graduate School of Science, Nagoya University, Chikusa-ku, 464-8602, Japan.
Yoshiki SakaiDivision of Biological Science, Graduate School of Science, Nagoya University, Chikusa-ku, 464-8602, Japan.
Naoki HisamotoDivision of Biological Science, Graduate School of Science, Nagoya University, Chikusa-ku, 464-8602, Japan g44177a@nucc.cc.nagoya-u.ac.jp i45556a@cc.nagoya-u.ac.jp.ORCID 0000-0002-1181-5980
Kunihiro MatsumotoDivision of Biological Science, Graduate School of Science, Nagoya University, Chikusa-ku, 464-8602, Japan g44177a@nucc.cc.nagoya-u.ac.jp i45556a@cc.nagoya-u.ac.jp.ORCID 0000-0003-4821-0106

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Aric L Daul, Ann E. Rougvie · 2012 to 2026
$7.5M
NIH HHS P40 OD010440
6 · The paper itself

Abstract

Axon regeneration following neuronal injury is an important repair mechanism that is not well understood at present. In

Indexed as

AnimalsAxonsCaenorhabditis elegansCaenorhabditis elegans ProteinsDiscoidin Domain Receptor 2Discoidin Domain ReceptorsFucosyltransferasesGlycosylationMAP Kinase Signaling SystemMutationNerve RegenerationNeuronsReceptor Protein-Tyrosine KinasesCaenorhabditis elegans ProteinsDiscoidin Domain Receptor 2Discoidin Domain ReceptorsFucosyltransferasesReceptor Protein-Tyrosine Kinasessvh-11 protein, C elegansSVH-2 protein, C elegansaxon regenerationCaenorhabditis elegansDDR-2N-glycosylation

Identifiers

PMID31371405
PMCPMC6781908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.